Graham Todd Danyleyko, PA-C

Graham Danyleyko practices at Hoag Urgent Care Sand Canyon in Irvine, California.

Graham Danyleyko's NPI, 1922087659, was assigned on January 11, 2006. Graham Danyleyko holds Washington license 10004686.

Graham Danyleyko's primary practice is Hoag Urgent Care Sand Canyon, at 16205 Sand Canyon Ave, Irvine, CA 92618. The practice phone is (949) 557-0000.

Graham Danyleyko's primary practice is Hoag Urgent Care Sand Canyon in Irvine, California. Graham Danyleyko is also affiliated with Hoag Hospital Newport Beach. The medical group on file is Hoag Clinic. Dmand AI also links Graham Danyleyko to 3 more medical groups, each named with a free account. Graham Danyleyko's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Graham Danyleyko practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Graham Danyleyko's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Graham Danyleyko is licensed in Washington.

Dmand AI lists acute gastroduodenitis, acute sinusitis, acute skin infection, ankle or foot injury, broken or dislocated ankle/ or foot, conjunctivitis, contact dermatitis and diabetic emergency among the conditions Graham Danyleyko treats.

CMS data shows 683 Medicare services from Graham Danyleyko across 9 procedure codes in 2024, for 485 Medicare patients. Medicare paid $36,383 for them. Every service was in an office.

CMS counts 485 Medicare patients who saw Graham Danyleyko in 2024. The largest group is 65 to 74, with 214 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Graham Danyleyko's median patient age at 46, with 57% women.

In 2024, Graham Danyleyko wrote 381 Medicare Part D claims for 301 patients. 94% of them were for generic drugs. CMS names the drug for 289 of them, across 11 drugs with 11 or more claims each, at $3,386 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Graham Danyleyko for performance year 2024, reported as part of a group. Graham Danyleyko accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Graham Danyleyko from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Medline Industries, Inc. paid the most, $19.